American Well Corp
No enriched coverage for $AMWL in the last 7 days.
No SEC Form 4 filings for $AMWL in the last 30 days.
American Well Corporation (AMWL) reported its first-quarter 2026 results, showing shrinking losses despite a year-over-year revenue decline. The company achieved $54.9 million in revenue, a net loss of $10.3 million, and an adjusted EBITDA loss of $3.1 million. Amwell reaffirmed its full-year 2026 revenue guidance and updated its adjusted EBITDA outlook, maintaining its target for positive cash flow from operations in Q4 2026.
Amwell Corporation (NYSE: AMWL) reported significant improvements in its 2025 financial results, sharply reducing its net loss to $95.0 million from $212.6 million in 2024 and improving Adjusted EBITDA to $(39.9) million from $(134.4) million. Despite the strong performance in 2025, the company issued cautious guidance for 2026, forecasting lower revenue of $195-$205 million, but projecting continued improvement in Adjusted EBITDA to $(24)-$(18) million, with the goal of achieving positive cash flow from operations by Q4 2026. The company's strategic shift towards a leaner, more efficient model, focusing on its Technology Enabled Care platform, is highlighted as key to its transformation and future sustainability.
HIMS faces rising regulatory strain, margin pressure and competition despite strong revenue momentum.
